中国炎症性肠病内镜诊治专家共识（2024，广州）

Chinese expert consensus on endoscopic diagnosis and treatment for inflammatory bowel diseases (2024, Guangzhou)

摘要:

炎症性肠病（inflammatory bowel disease，IBD）是一类病因未明、诊疗过程复杂的肠道炎症性疾病，其诊断及鉴别诊断困难，患病人数呈现快速增长趋势，且难治患者较多。国内消化内镜技术飞速发展，在IBD诊治领域的应用不断更新。因此，中华医学会消化内镜学分会结直肠学组牵头，联合国内消化、消化内镜专家共同制定了本共识。本共识主要从以下5个方面：IBD内镜检查的适应证与禁忌证、溃疡性结肠炎内镜诊断、克罗恩病内镜诊断、IBD内镜治疗和IBD内镜随访，分别进行阐述，为IBD内镜诊治提供指导性建议，以期提高国内IBD内镜诊治的整体水平。

Abstract:

Inflammatory bowel diseases (IBD) is a complex group of inflammatory disorders mainly affecting the gastrointestinal tract with an unknown etiology, which is characterized by difficult diagnosis and differentiation. The number of affected individuals is rapidly increasing with a large part of difficult‑to‑treat patients. With the rapid development of digestive endoscopy in China, its application in the diagnosis and treatment of IBD is constantly evolving. Therefore, led by Colorectal Group, Digestive Endoscopy Branch of Chinese Medical Association and supported by domestic digestive and endoscopy experts, this consensus has been reached. This consensus primarily focuses on the following five aspects: indications and contraindications for endoscopic examination in IBD, endoscopic diagnosis of ulcerative colitis, endoscopic diagnosis of Crohn disease, endoscopic treatment of IBD, and endoscopic follow‑up of IBD, providing references for the endoscopic diagnosis and treatment of IBD for improving the overall quality of IBD endoscopic care in China.